Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1982
[Dyskeratosis congenita (Zinsser-Engman-Cole syndrome) and Fanconi's anemia]R Korz, V Wienert, H KnechtenZeitschrift Fur Arztliche Fortbildung|August 1, 1996
[Evaluation of HIV-related continuing education programs for established physicians]A Goetzenich, H Knechten, G Flatten, et al.HIV Clinical Trials|October 9, 2001
Switch to efavirenz in a protease inhibitor-containing regimenH Knechten, K H Stürner, C Höhn, et al.Deutsche Medizinische Wochenschrift (1946)|August 18, 2006
[High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review]F A Mosthaf, N J Hanhoff, A Goetzenich, et al.European Journal of Medical Research|April 16, 2002
Treatment of HIV-associated wasting with recombinant human growth hormone: monitoring of body composition changes by bioelectrical impedance analysis (BIA)H Jäger, H Knechten, A Moll, et al.Medical Microbiology and Immunology|November 16, 2014
Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitorsF Wiesmann, G Naeth, C Sarrazin, et al.Deutsche Medizinische Wochenschrift (1946)|December 10, 2009
[Pre-exposure prophylaxis in HIV--a vision or soon a reality?]S Reuter, D Meyer, H Knechten, et al.HIV Medicine|June 13, 2002
Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatmentS Mauss, M Corzillius, E Wolf, et al.European Journal of Medical Research|August 2, 2007
Differences of nine drug resistance interpretation systems in predicting short-term therapy outcomes of treatment-experienced HIV-1 infected patients: a retrospective observational cohort studyM Helm, H Walter, R Ehret, et al.Medical Microbiology and Immunology|December 16, 2015
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatmentF Wiesmann, G Naeth, A Berger, et al.Pageof 2